SLC5A2 and diabetes mellitus: Although some authors have speculated a downregulation of the RAAS during SGLT2 inhibition in diabetes (15), this has not been supported by clinical data, which even suggest an increase in circulating RAAS activity as a consequence of the diuretic effect of flozins (22, 41).